These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29446061)

  • 1. Viewpoints of dentists on the use of bisphosphonates in rheumatology patients.
    Daron C; Deschaumes C; Soubrier M; Mathieu S
    Int Dent J; 2018 Aug; 68(4):279-286. PubMed ID: 29446061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knowledge, practices, and opinions of ontario dentists when treating patients receiving bisphosphonates.
    Alhussain A; Peel S; Dempster L; Clokie C; Azarpazhooh A
    J Oral Maxillofac Surg; 2015 Jun; 73(6):1095-105. PubMed ID: 25843818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates, healthcare professionals and oral health.
    Raj DV; Abuzar M; Borromeo GL
    Gerodontology; 2016 Mar; 33(1):135-43. PubMed ID: 25039439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bisphosphonate-associated Osteonecrosis of the Jaws: a Survey of the Level of Knowledge of Dentists about the Risks of Bisphosphonate Therapy.
    Hristamyan-Cilev MA; Pechalova PP; Raycheva RD; Hristamyan VP; Kevorkyan AK; Stoilova YD
    Folia Med (Plovdiv); 2019 Jun; 61(2):303-311. PubMed ID: 31301653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of dental care providers in the management of patients prescribed bisphosphonates: brief clinical guidance.
    Abed HH; Al-Sahafi EN
    Gen Dent; 2018; 66(3):18-24. PubMed ID: 29714695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medication-Related Osteonecrosis of the Jaw Around Dental Implants: Implant Surgery-Triggered or Implant Presence-Triggered Osteonecrosis?
    Giovannacci I; Meleti M; Manfredi M; Mortellaro C; Greco Lucchina A; Bonanini M; Vescovi P
    J Craniofac Surg; 2016 May; 27(3):697-701. PubMed ID: 27092912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of the literature on osteonecrosis of the jaw in patients with osteoporosis treated with oral bisphosphonates: prevalence, risk factors, and clinical characteristics.
    Pazianas M; Miller P; Blumentals WA; Bernal M; Kothawala P
    Clin Ther; 2007 Aug; 29(8):1548-58. PubMed ID: 17919538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How patients' lack of knowledge about oral bisphosphonates can interfere with medical and dental care.
    Migliorati CA; Mattos K; Palazzolo MJ
    J Am Dent Assoc; 2010 May; 141(5):562-6. PubMed ID: 20436104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bisphosphonate-related osteonecrosis of the jaw: position paper from the Allied Task Force Committee of Japanese Society for Bone and Mineral Research, Japan Osteoporosis Society, Japanese Society of Periodontology, Japanese Society for Oral and Maxillofacial Radiology, and Japanese Society of Oral and Maxillofacial Surgeons.
    Yoneda T; Hagino H; Sugimoto T; Ohta H; Takahashi S; Soen S; Taguchi A; Toyosawa S; Nagata T; Urade M
    J Bone Miner Metab; 2010 Jul; 28(4):365-83. PubMed ID: 20333419
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knowledge and attitudes of Brazilian dental students and dentists regarding bisphosphonate-related osteonecrosis of the jaw.
    de Lima PB; Brasil VL; de Castro JF; de Moraes Ramos-Perez FM; Alves FA; dos Anjos Pontual ML; da Cruz Perez DE
    Support Care Cancer; 2015 Dec; 23(12):3421-6. PubMed ID: 25757408
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knowledge and attitude regarding bisphosphonates and related osteonecrosis among Turkish dentist: A cross sectional study.
    Ozkan E; Bereket MC; Ozkan N
    Niger J Clin Pract; 2021 Oct; 24(10):1485-1491. PubMed ID: 34657014
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw: balancing the benefits and risks of oral bisphosphonate treatment for osteoporosis.
    Jeffcoat M; Watts NB
    Gen Dent; 2008; 56(1):96-102; quiz 103-4, 111-2. PubMed ID: 18254568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The rare case of osteonecrosis of the jaws in a patient treated with bisphosphonates for osteoporosis].
    Lewandowski B; Brodowski R; Kość T; Migut M; Wojnar J
    Przegl Lek; 2016; 73(1):46-8. PubMed ID: 27120948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness and education of patients receiving bisphosphonates.
    Bauer JS; Beck N; Kiefer J; Stockmann P; Wichmann M; Eitner S
    J Craniomaxillofac Surg; 2012 Apr; 40(3):277-82. PubMed ID: 21612939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Bisphosphonate-associated osteonecrosis of the jaw].
    Koy S; Schubert M; Koy J; Ney M; Lauer G; Sabatowski R
    Schmerz; 2015 Apr; 29(2):171-8. PubMed ID: 25860198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Strategy against the Osteonecrosis of the Jaw Associated with Nitrogen-Containing Bisphosphonates (N-BPs): Attempts to Replace N-BPs with the Non-N-BP Etidronate.
    Oizumi T; Yamaguchi K; Sato K; Takahashi M; Yoshimura G; Otsuru H; Tsuchiya M; Hagiwara Y; Itoi E; Sugawara S; Takahashi T; Endo Y
    Biol Pharm Bull; 2016; 39(9):1549-54. PubMed ID: 27582334
    [TBL] [Abstract][Full Text] [Related]  

  • 17. External auditory canal and middle ear cholesteatoma and osteonecrosis in bisphosphonate-treated osteoporosis patients: a Danish national register-based cohort study and literature review.
    Thorsteinsson AL; Vestergaard P; Eiken P
    Osteoporos Int; 2014 Jul; 25(7):1937-44. PubMed ID: 24664275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients on bisphosphonates: the practice of primary care dentists before and after the publication of national guidance.
    Bonetti DL; Clarkson JE; Elouafkaoui P; Stirling DA; Young L; Templeton AR
    Br Dent J; 2014 Dec; 217(12):E25. PubMed ID: 25525031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bisphosphonate use and the risk of adverse jaw outcomes: a medical claims study of 714,217 people.
    Cartsos VM; Zhu S; Zavras AI
    J Am Dent Assoc; 2008 Jan; 139(1):23-30. PubMed ID: 18167381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness of the risk of developing medication-related osteonecrosis of the jaw among bisphosphonate users.
    El-Ma'aita A; Da'as N; Al-Hattab M; Hassona Y; Al-Rabab'ah M; Al-Kayed MA
    J Int Med Res; 2020 Sep; 48(9):300060520955066. PubMed ID: 32924697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.